Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury

Journal of Vascular Surgery

Volumn 48, Issue 1, 2008, Pages 201-209

  Han, Yaling ^a   Guo, Liang ^a   Yan, Chenghui ^a   Guo, Peng ^a   Deng, Jie ^a   Mai, Xiaoyan ^a   Kang, Jian ^a   Li, Shaohua ^b  

^a SHENYANG NORTHERN HOSPITAL   (China)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; BROXURIDINE; CD31 ANTIGEN; CELLULAR REPRESSOR OF E1A STIMULATED PROTEIN; GLYCOPROTEIN; GREEN FLUORESCENT PROTEIN; MYOSIN HEAVY CHAIN; SODIUM CHLORIDE;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; BALLOON CATHETER; CAROTID ARTERIOGRAPHY; CAROTID ARTERY INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INCUBATION TIME; ISOLATED ARTERY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RANDOMIZATION; SMOOTH MUSCLE FIBER; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BALLOON DILATATION; BLOTTING, WESTERN; CAROTID ARTERY, COMMON; CELL PROLIFERATION; DNA, COMPLEMENTARY; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; RABBITS; REPRESSOR PROTEINS; TUNICA MEDIA;

EID: 45549106317     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.01.061     Document Type: Article

References (27)

1. Daemen J., and Serruys P.W. Drug-eluting stent update 2007: Part II: Unsettled issues. Circulation 116 (2007) 961-968
2. Weintraub W.S. The pathophysiology and burden of restenosis. Am J Cardiol 100 (2007) 3K-9K
3. Albrecht T., Speck U., Baier C., Wolf K.J., Bohm M., and Scheller B. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol 42 (2007) 579-585
4. Hao H., Gabbiani G., and Bochaton-Piallat M.-L. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23 (2003) 1510-1520
5. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol 81 (2000) 173-182
6. Schmidt A., Vlodavsky I., Volker W., and Buddecke E. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound. Atherosclerosis 147 (1999) 387-397
7. Daemen J., and Serruys P.W. Drug-eluting stent update 2007: Part I: a survey of current and future generation drug-eluting stents: Meaningful advances or more of the same?. Circulation 116 (2007) 316-328
8. Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., and Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
9. Trabattoni D., Fabbiocchi F., Montorsi P., Ravagnani P., Galli S., Teruzzi G., et al. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: Analysis of a single center registry. Catheter Cardiovasc Interv 70 (2007) 415-421
10. Sarkar K., Sharma S.K., Sachdeva R., Romeo F., Garza L., and Mehta J.L. Coronary artery restenosis: vascular biology and emerging therapeutic strategies. Expert Rev Cardiovasc Ther 4 (2006) 543-556
11. Veal E., Eisenstein M., Tseng Z.H., and Gill G. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol Cell Biol 18 (1998) 5032-5041
12. Sacher M., Di Bacco A., Lunin V.V., Ye Z., Wagner J., Gill G., and Cygler M. The crystal structure of creg, a secreted glycoprotein involved in cellular growth and differentiation. Proc Natl Acad Sci U S A 102 (2005) 18326-18331
13. Di Bacco A., and Gill G. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor. Oncogene 22 (2003) 5436-5445
14. Veal E., Groisman R., Eisenstein M., and Gill G. The secreted glycoprotein CREG enhances differentiation of ntera-2 human embryonal carcinoma cells. Oncogene 19 (2000) 2120-2128
15. Han Y.L., Yan C.H., Liu H.W., Hu Y., Kang J., Wang X.Z., and Li S.H. Overexpression of the cellular repressor of E1A-stimulated-genes regulate the rat primary VSMCs differentiation in vitro. Prog Biochem Biophys 31 (2004) 1099-1105
16. Han Y.L., Xu H.M., Yan C.H., Hu Y., Kang J., and Liu H.W. The cellular repressor of e1a-stimulated genes promotes human vsmcs differentiation in vitro mediated by RHOA and SRF. Prog Biochem Biophys 33 (2006) 438-445
17. Han Y.L., Liu H.W., Kang J., Yan C.H., Wang X.Z., Zhao L.Y., and Li S.H. Expression of cellular repressor of e1a-stimulated genes in vascular smooth muscle cells of different phenotypes. Zhonghua yi xue za zhi 85 (2005) 49-53
18. Han Y.L., Hu Y., Liu H.W., Kang J., Yan C.H., and Li S.H. The cellular repressor of E1A-stimulated genes induces differentiation and migration of human vascular smooth muscle cells. Prog Biochem Biophys 32 (2005) 517-522
19. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95 (1998) 2509-2514
20. Chih-Yang C., Yih-Sharng C., Ming-Chieh M., and Chou-Fong C. Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats. J Vasc Surg 45 (2007) 804-811
21. Regan C.P., Adam P.J., Madsen C.S., and Owens G.K. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest 106 (2000) 1139-1147
22. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801
23. Ohno T., Gordon D., San H., Pompili V.J., Imperiale M.J., Nabel G.J., and Nabel E.G. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265 (1994) 781-784
24. Chang M.W., Ohno T., Gordon D., Lu M.M., Nabel G.J., Nabel E.G., and Leiden J.M. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol Med 1 (1995) 172-181
25. Chang M.W., Barr E., Lu M.M., Barton K., and Leiden J.M. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96 (1995) 2260-2268
26. Claudio P.P., Fratta L., Farina F., Howard C.M., Stassi G., Numata S., et al. Adenoviral rb2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty. Circ Res 85 (1999) 1032-1039
27. Kawaguchi R., Angiolillo D.J., Futamatsu H., Suzuki N., Bass T.A., and Costa M.A. Stent thrombosis in the era of drug eluting stents. Minerva Cardioangiol 55 (2007) 199-211